HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Arndt Hartmann Selected Research

Adenolymphoma

9/2015Intraparotid classical and nodular lymphocyte-predominant Hodgkin lymphoma: pattern analysis with emphasis on associated lymphadenoma-like proliferations.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Arndt Hartmann Research Topics

Disease

135Neoplasms (Cancer)
12/2015 - 03/2002
50Carcinoma (Carcinomatosis)
12/2015 - 05/2002
44Breast Neoplasms (Breast Cancer)
04/2015 - 01/2004
36Urinary Bladder Neoplasms (Bladder Cancer)
12/2015 - 03/2002
19Prostatic Neoplasms (Prostate Cancer)
09/2015 - 04/2005
17Microsatellite Instability
03/2015 - 12/2002
16Neoplasm Metastasis (Metastasis)
09/2014 - 11/2003
13Colorectal Neoplasms (Colorectal Cancer)
11/2015 - 12/2002
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2014 - 11/2003
8Renal Cell Carcinoma (Grawitz Tumor)
01/2014 - 03/2003
6Inflammation
06/2015 - 01/2010
6Melanoma (Melanoma, Malignant)
01/2015 - 01/2004
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
06/2014 - 11/2003
5Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
11/2014 - 12/2002
5Hepatocellular Carcinoma (Hepatoma)
01/2014 - 05/2005
5Adenoma (Adenomas)
02/2012 - 04/2007
4Ovarian Neoplasms (Ovarian Cancer)
10/2015 - 03/2007
4Lung Neoplasms (Lung Cancer)
06/2014 - 05/2007
4Disease Progression
02/2013 - 04/2010
4Colonic Neoplasms (Colon Cancer)
12/2012 - 09/2004
3Hyperplasia
08/2012 - 04/2008
3Infection
01/2011 - 10/2003
3Adenocarcinoma
05/2009 - 11/2003
3Nevus (Nevi)
01/2009 - 08/2006
2Lymphoma (Lymphomas)
09/2015 - 06/2014
2Sialadenitis
09/2015 - 03/2011
2Fibrosis (Cirrhosis)
06/2015 - 10/2003
2Sarcoma (Soft Tissue Sarcoma)
06/2014 - 01/2014
2Anoxia (Hypoxia)
06/2014 - 04/2009
2Fatty Liver
04/2014 - 01/2010
2Obesity
04/2014 - 03/2009
2Crohn Disease (Crohn's Disease)
01/2014 - 01/2012
2Salivary Gland Neoplasms (Salivary Gland Cancer)
05/2013 - 06/2008
2Ulcerative Colitis
03/2013 - 01/2012
2Necrosis
09/2012 - 04/2005

Drug/Important Bio-Agent (IBA)

24Messenger RNA (mRNA)IBA
03/2015 - 10/2003
21DNA (Deoxyribonucleic Acid)IBA
01/2015 - 08/2002
19Proteins (Proteins, Gene)IBA
03/2015 - 12/2002
17N-methylsuccinimideIBA
11/2014 - 12/2002
16ParaffinIBA
01/2015 - 08/2002
14Biological Markers (Surrogate Marker)IBA
09/2015 - 01/2008
13Estrogens (Estrogen)FDA Link
11/2014 - 11/2008
11HormonesIBA
04/2015 - 11/2008
11Formaldehyde (Formol)FDA Link
01/2015 - 04/2005
8Progesterone Receptors (Progesterone Receptor)IBA
11/2014 - 01/2009
8Codon (Codons)IBA
08/2014 - 05/2002
8RNA (Ribonucleic Acid)IBA
06/2014 - 10/2003
8MicroRNAs (MicroRNA)IBA
02/2014 - 04/2010
7Transcription Factors (Transcription Factor)IBA
01/2015 - 01/2008
5Cisplatin (Platino)FDA LinkGeneric
04/2014 - 08/2010
5Phenobarbital (Luminal)FDA Link
01/2014 - 01/2007
5SERPIN-B5 (maspin)IBA
05/2012 - 04/2005
5Complementary DNA (cDNA)IBA
01/2009 - 04/2004
4FRZB proteinIBA
10/2015 - 04/2004
4Phosphotransferases (Kinase)IBA
06/2014 - 01/2004
4Prostate-Specific Antigen (Semenogelase)IBA
03/2013 - 11/2008
4karyopherin alpha 2IBA
03/2011 - 07/2006
4Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA
11/2009 - 08/2007
3death-associated protein kinaseIBA
11/2015 - 12/2012
3VimentinIBA
10/2015 - 07/2012
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2015 - 02/2013
3Non-alcoholic Fatty Liver DiseaseIBA
06/2015 - 01/2010
3AntibodiesIBA
05/2015 - 01/2006
3Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
04/2015 - 08/2006
3Estrogen Receptor alphaIBA
05/2014 - 03/2009
3Carrier Proteins (Binding Protein)IBA
04/2014 - 06/2011
3Glucose (Dextrose)FDA LinkGeneric
04/2014 - 04/2009
3Staphylococcal Protein A (A, Protein)IBA
01/2014 - 01/2012
3Cadherins (E-Cadherin)IBA
01/2014 - 02/2009
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2012 - 08/2005
3Epidermal Growth Factor Receptor (EGF Receptor)IBA
04/2010 - 01/2006
3trastuzumab (Herceptin)FDA Link
01/2008 - 04/2005
2Aquaporin 3IBA
12/2015 - 01/2012
2tebufenozide (Mimic)IBA
09/2015 - 04/2010
2bevacizumabFDA Link
07/2015 - 07/2010
2calretininIBA
05/2015 - 01/2014
2DNA topoisomerase II alphaIBA
04/2015 - 01/2008
2PlatinumIBA
01/2015 - 03/2007
2Telomerase (Telomerase Reverse Transcriptase)IBA
01/2015 - 03/2002
2Succinate Dehydrogenase (Fumarate Reductase)IBA
12/2014 - 08/2014
2tyrosine receptor (receptor, tyrosine)IBA
06/2014 - 04/2010
2InterferonsIBA
12/2013 - 01/2008
2CytokinesIBA
12/2013 - 03/2011
2I-antigenIBA
05/2013 - 04/2010
2Protein Isoforms (Isoforms)IBA
05/2013 - 01/2011
2AntigensIBA
05/2013 - 04/2012
2Small Interfering RNA (siRNA)IBA
12/2012 - 01/2011
2Clear-cell metastatic renal cell carcinomaIBA
09/2012 - 01/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2012 - 08/2012
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2012 - 01/2009
2Keratins (Keratin)IBA
07/2012 - 03/2011

Therapy/Procedure

22Drug Therapy (Chemotherapy)
04/2015 - 12/2003
14Cystectomy
10/2013 - 11/2002
10Lasers (Laser)
01/2012 - 12/2002
8Prostatectomy (Retropubic Prostatectomy)
07/2015 - 11/2008
8Adjuvant Chemotherapy
04/2015 - 08/2010
3Aftercare (After-Treatment)
07/2015 - 10/2006
3Nephrectomy
01/2014 - 09/2012
2Neoadjuvant Therapy
02/2013 - 01/2011
2Radiotherapy
12/2012 - 12/2003